David L. Cutler
David L. Cutler publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as Cancer Treatment and Pharmacology, Diabetes Treatment and Management and Colorectal Cancer Treatments and Studies.
- World rank
- #1,948,523 of 7,710,434 ranked researchers
- Rank in United States
- #593,435 of 1,627,098
- Works
- 181
- Citations
- 5.1k
- Citations per work
- 28.4
What does David L. Cutler research?
David L. Cutler's work is mostly in Medicine (34%), Biochemistry, Genetics and Molecular Biology (6%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else9653.1%
- Health Sciences6234.1%
- Medicine6234.1%
- Life Sciences2312.8%
- 1Oncology19% of their works
- 2Molecular Biology6% of their works
- 3Immunology6% of their works
- 4Pulmonary and Respiratory Medicine6% of their works
- 5Hematology5% of their works
- 6Epidemiology5% of their works
Research topics
Which keywords describe David L. Cutler's research?
The keywords of their largest research topics: Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Cardiovascular Outcomes, Cetuximab, KRAS Mutations, Type 2 Diabetes, Aspirin and Clopidogrel.
- Treatment
- Pattern Recognition Receptors
- Hepatitis C Virus
- Skin Cancers
- Clopidogrel
- Type 2 Diabetes
- Cetuximab
- Taxanes
- Chemotherapy-Induced Peripheral Neuropathy
- Cardiovascular Outcomes
- KRAS Mutations
- Aspirin
- Nonmelanoma Skin Cancer
- ATP-dependent Transporters
- Multidrug Resistance
- Toll-like Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Chemotherapy-Induced Peripheral Neuropathy301 topic
- Taxanes301 topic
- Cardiovascular Outcomes121 topic
- Cetuximab121 topic
- KRAS Mutations121 topic
- Type 2 Diabetes121 topic
- Aspirin111 topic
- Clopidogrel111 topic
- Nonmelanoma Skin Cancer111 topic
- Skin Cancers111 topic
- ATP-dependent Transporters101 topic
- Hepatitis C Virus101 topic
- Multidrug Resistance101 topic
- Pattern Recognition Receptors101 topic
- Toll-like Receptors101 topic
- Treatment101 topic
Where does David L. Cutler work?
David L. Cutler's main affiliation in the publication record is Athenex (United States), United States.
How many publications and citations does David L. Cutler have?
OpenAlex counts 181 works and 5,144 citations for David L. Cutler, an h-index of 34, ranking #1,948,523 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named David L. Cutler
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David L. Cutler. Posts are plain text and can be reported.